NPI registry status
Active
2026 NPPES data Interventional Pain Medicine Physician NPI 1730150194 MD
Verify on CMS → Mark Ellis, MD
Interventional Pain Medicine Physician in Athens, Georgia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,528 in Interventional Pain Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
19K
Medicare Part D claims · 2K beneficiaries · Interventional Pain Medicine Physician avg: 2K
Generic prescribing
97%
generic claims · 3% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
92.4/100
▲ 9 pts above national avg 83.1 · Exceptional
Industry payments
$48.93
2 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Mark Ellis, MD reported a CMS MIPS final score of 92.4/100 - above the 83.1 national average - and filed 19,390 Medicare Part D claims in 2023.
- 92.4/100
- MIPS score · +9 vs avg
- 19K
- Part D claims, 2023
- 97%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Mark Ellis, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
92 Top 32% higher than 68% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mark Ellis, MD sits
This provider among interventional pain medicine physician peers
Across the 546 interventional pain medicine physician providers who report both Medicare Part D prescribing and a MIPS quality score, Mark Ellis, MD writes more Part D claims than 98% of them and scores higher on MIPS quality than 80% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one interventional pain medicine physician peer from a representative sample of 60; the gold marker is Mark Ellis, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Mark Ellis, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mark Ellis, MD?
High performer (top quartile)Primary specialty
Interventional Pain Medicine Physician
Medicare Part D claims
19,390 9× vs specialty avg
MIPS final score
92.4/100 9.3 pts vs avg
Specialty distribution in Georgia
How Interventional Pain Medicine Physician compares to other specialties among Georgia providers
Medicare quality performance, MIPS
Mark Ellis, MD's 2023 MIPS final score plotted against the Interventional Pain Medicine Physician national average
- MIPS Final Score
- 92.4/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Interventional Pain Medicine Physician) - 92.4/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Mark Ellis, MD appears in the CMS NPPES registry as a Interventional Pain Medicine Physician provider holding MD credentials at 1765 OLD WEST BROAD ST, Athens, GA, 30606, with a listed phone of (706) 208-0451. NPI 1730150194 was issued on 02/01/2006.
Medicare Part D records for calendar year 2023 show 19,390 prescription claims written by this provider, covering 1,521 Medicare beneficiaries and totaling roughly $991K in drug spend, split 3% brand-name and 97% generic by claim count, with an opioid prescribing rate of 89.6%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 92.4/100 for the 2023 performance year (Quality 72.9), compared with the national average of 83.1.
Interventional Pain Medicine Physician is a narrow specialty nationwide, with 1,528 enrolled providers across 53 states and an average of 2,197 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1730150194 |
|---|---|
| Specialty | Interventional Pain Medicine Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 02/01/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
92.3583
Final Score
Avg: 83.1
72.8913
Quality
99
Promoting Interoperability
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Ellis, MD. Source: openpaymentsdata.cms.gov.
Total received
$49
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
Mark Ellis, MD - brand share 3.0%
Interventional Pain Medicine Physician average
3% brand-name claims vs 97% generic, on 19,390 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
19,390
Total Claims
$991K
Total Drug Cost
1,521
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 19,524
- Total Day Supply
- 534,611
- Brand vs Generic
- 3% brand / 97% generic
- Brand Drug Cost
- $234K
- Generic Drug Cost
- $757K
- Opioid Claims
- 17,371 (89.6% rate)
Patient Demographics
- Average Patient Age
- 66.3 years
- Avg HCC Risk Score
- 1.82
- Gender Split
- 61% female / 39% male
- Age Distribution
- <65: 584, 65-74: 615, 75-84: 280, 85+: 42
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mark Ellis, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
5,823 claims
- Oxycodone-Acetamin…
Oxycodone-Acetaminophen
5,387 claims
- Oxycodone Hcl
Oxycodone Hcl
2,646 claims
- Morphine Sulfate Er 1,011
Morphine Sulfate Er
1,011 claims
- Hydromorphone Hcl 809
Hydromorphone Hcl
809 claims
- Fentanyl 374
Fentanyl
374 claims
- Methadone Hcl 345
Methadone Hcl
345 claims
- Gabapentin 309
Gabapentin
309 claims
| Drug | Claims |
|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 5,823 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 5,387 |
| Oxycodone Hcl | 2,646 |
| Morphine Sulfate Er Morphine Sulfate | 1,011 |
| Hydromorphone Hcl | 809 |
| Fentanyl | 374 |
| Methadone Hcl | 345 |
| Gabapentin | 309 |
| Pregabalin | 232 |
| Morphine Sulfate | 184 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Interventional Pain Medicine Physician in GA →
All providers in Georgia →
Compare specialties →
Interventional Pain Medicine Physician Overview
How Mark Ellis, MD fits within the Interventional Pain Medicine Physician landscape nationally.
1,528
Interventional Pain Medicine Physician Providers in US
53
States with Interventional Pain Medicine Physician
2,197
Avg Claims per Provider
Mark Ellis, MD's 19,390 claims are above the specialty average of 2,197.
Nearby Interventional Pain Medicine Physician Providers in Georgia
Other clinicians with the same primary specialty enrolled in Georgia, drawn from the same CMS NPPES roster as Ellis.
Dr. Chad Achilles
M.D.
Atlanta, GA
Dr. Naureen Adam
M.D.
Atlanta, GA
Dr. Brian Adams
MD
Gainesville, GA
Dr. Jolaade Adebayo
M.D.
Gainesville, GA
Dr. Randall Berinhout
M.D.
Stockbridge, GA
Compare Interventional Pain Medicine Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Georgia medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Interventional Pain Medicine Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Georgia
Frequently Asked Questions
What is Mark Ellis, MD's specialty? ▼
Mark Ellis, MD specializes in Interventional Pain Medicine Physician and practices in Athens, Georgia. Credentials: MD.
How much does Mark Ellis, MD prescribe under Medicare Part D? ▼
In 2023, Mark Ellis, MD wrote 19,390 Medicare Part D claims totaling $991K in drug costs for 1,521 beneficiaries.
What is Mark Ellis, MD's Medicare quality score? ▼
Mark Ellis, MD has a CMS MIPS Final Score of 92.4/100 (Quality: 72.9). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mark Ellis, MD located? ▼
Mark Ellis, MD is located at 1765 OLD WEST BROAD ST, Athens, GA, 30606. Phone: (706) 208-0451.
What is Mark Ellis, MD's NPI number? ▼
Mark Ellis, MD's National Provider Identifier (NPI) is 1730150194, issued on 02/01/2006.
Does Mark Ellis, MD prescribe more brand-name or generic drugs? ▼
Mark Ellis, MD's prescribing is 3% brand-name and 97% generic drugs by claim count, with $234K in brand drug costs.
Does Mark Ellis, MD prescribe opioids? ▼
Yes, Mark Ellis, MD had 17,371 opioid claims in 2023 with an opioid prescribing rate of 89.6%.
How many Interventional Pain Medicine Physician providers are there in the US? ▼
There are 1,528 Interventional Pain Medicine Physician providers across 53 states in the US. The average Interventional Pain Medicine Physician provider writes 2,197 Medicare Part D claims per year.
What drugs does Mark Ellis, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Mark Ellis, MD's most frequently prescribed drugs include Hydrocodone-Acetaminophen, Oxycodone-Acetaminophen, Oxycodone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Ellis, MD accept Medicare? ▼
Mark Ellis, MD appears in CMS Medicare data with 19,390 Part D claims and 1,521 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Ellis, MD's credentials? ▼
Mark Ellis, MD's NPI is 1730150194 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.